ArticleThe Journal of clinical investigation2016

Protease-resistant modified human β-hexosaminidase B ameliorates symptoms in GM2 gangliosidosis model.

Keisuke Kitakaze et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.